SunCoke Energy (SXC) Q4 2024 earnings summary
Event summary combining transcript, slides, and related documents.
Q4 2024 earnings summary
9 Jan, 2026Executive summary
Achieved record safety performance in 2024 with a TRIR of 0.5, highlighting safety as a top priority.
Delivered consolidated Adjusted EBITDA of $272.8 million for 2024, exceeding guidance, driven by strong logistics performance and a one-time gain from eliminating most black lung liabilities.
Generated $96 million in free cash flow, surpassing the high end of guidance.
Quarterly dividend increased by 20% to $0.12 per share in 2024.
Coke plants operated at full capacity, with all non-contracted tons sold into foundry and spot blast coke markets.
Financial highlights
Full year 2024 net income was $1.12 per share, up $0.44 from 2023, mainly due to lower depreciation, a one-time DOL gain, and lower tax expense.
Consolidated Adjusted EBITDA for Q4 2024 was $66.1 million, up $3.8 million year-over-year.
Domestic Coke Adjusted EBITDA for 2024 was $234.7 million; logistics segment Adjusted EBITDA was $50.4 million.
Operating cash flow in 2024 was $168.8 million; capital expenditures were $72.9 million, below guidance.
Ended 2024 with $189.6 million in cash and $350 million revolver fully available, totaling $540 million in liquidity.
Outlook and guidance
2025 consolidated Adjusted EBITDA expected between $210–$225 million, reflecting lower margins in Domestic Coke and logistics.
Domestic Coke Adjusted EBITDA projected at $185–$192 million, with 4 million tons in sales, 3.3 million under long-term contracts.
Logistics Adjusted EBITDA expected at $45–$50 million; no index-based price adjustment benefit assumed in guidance.
2025 CapEx expected at $65 million, below the typical $75–$80 million run rate.
Free cash flow for 2025 projected at $100–$115 million.
Latest events from SunCoke Energy
- 2026 outlook projects EBITDA and FCF growth after a challenging 2025 with one-time impacts.SXC
Q4 202517 Feb 2026 - Q3 adjusted EBITDA hit $75.3M, net income rose, and 2024 guidance was raised on regulatory gain.SXC
Q3 202413 Feb 2026 - Q2 Adjusted EBITDA hit $63.5M, with a 20% dividend hike and strong full-year outlook.SXC
Q2 20242 Feb 2026 - 2025 meeting to vote on directors, pay, and auditor amid strong results and robust governance.SXC
Proxy Filing1 Dec 2025 - Virtual meeting to elect directors, approve pay, and ratify auditor on May 15, 2025.SXC
Proxy Filing1 Dec 2025 - Q1 2025 profit fell on weak coke sales, but guidance and liquidity remain strong.SXC
Q1 202528 Nov 2025 - $325M acquisition expands reach, diversifies earnings, and delivers immediate accretion and synergies.SXC
M&A Announcement25 Nov 2025 - Q2 2025 earnings fell, but liquidity is strong and a $325M acquisition closes August 1.SXC
Q2 202516 Nov 2025 - Q3 2025 Adjusted EBITDA dropped to $59.1M, with FY guidance cut to $220–$225M after a contract breach.SXC
Q3 202513 Nov 2025